The Consumer Technology Association (CTA) recently announced the winners of the Innovation Awards at CES® 2026. Eieling Technology’s FattaLab® Fatty Liver Diagnostic Device stood out from numerous competitors, winning the CES® 2026 Innovation Award thanks to its outstanding innovative design and technological strength. This international award not only fully affirms Eieling Technology’s continuous exploration in the field of liver health but also highly recognizes its research capabilities and product innovation.
The CES® Innovation Awards, hosted by the Consumer Technology Association (CTA), are considered the “Oscars” of the global consumer technology industry. The judging panel comprises top designers, engineers, and media professionals from around the world, conducting rigorous evaluations across multiple dimensions, including product innovation, functionality, user experience, and aesthetic design, to recognize technological products that have made outstanding contributions to the global consumer electronics field.
A Breakthrough Strategy: From “Passive Healthcare” to “Proactive Health”
Accurate detection of liver fat has long been a challenge in the field of health management. Traditional detection methods are not only costly and complex, but their results are also easily affected by factors such as the operator’s experience and the examinee’s body type. The launch of FattaLab® solves these problems. This product uses the exclusive patented Auto Intra-Focus Fusion human liver fat detection algorithm, which automatically adjusts the ROI to effectively eliminate interference from non-liver tissues. It is particularly well-suited to the growing detection needs of obese individuals, achieving rapid and accurate detection while significantly reducing dependence on operators and the testing environment.
FattaLab® can output quantitative liver fat data within 30 seconds. Its lightweight, convenient, and personalized design not only breaks the spatial limitations of traditional testing but also further realizes the possibility of “at-home liver health management.” FattaLab®’s innovation lies not only in its efficient testing but also in unlocking diverse application scenarios. The device features one-click measurement, and monitoring data can be synchronized via a smart app, automatically generating reports, allowing everyone to enjoy precise “data-driven” health management. As a convenient and fast daily health management tool, FattaLab® sets a new benchmark for metabolic health management.
Leading a new era in fatty liver screening, Chinese scientific and technological innovation once again takes center stage on the international stage
In May 2025, Eieling Technology launched the FattaLab® Fatty Liver Diagnostic Device. This product has garnered significant market attention since its release. Weighing only 120 grams, the device is easy to hold and allows for convenient testing anytime, anywhere. FattaLab® can seamlessly integrate with digital therapy companies, physician groups, and other organizations to establish collaborative programs, thereby accurately reaching more high-risk individuals and expanding the service scenarios and commercial boundaries of liver health management.
From January 6th to 9th, 2026, Eieling Technology will showcase FattaLab® at the Consumer Electronics Show (CES) in Las Vegas, USA, the world’s premier technology event. We will be exhibiting at the Hong Kong Science and Technology Exhibition Center (Booth No.: 50732), where we will gather with international experts and industry leaders to discuss the future development of liver screening technology and demonstrate China’s technological prowess.
